Enantioselective Heck Reaction
Organometallics, Vol. 18, No. 4, 1999 677
3H), 3.41 (s, 3H), 4.81 (m, b, 1H), 4.98 (m, b, 1H), 6.25 (m,
(C4), 126.8 (dd, C3, J PC ) 8.7, 4.6 Hz), 123.7-137.2 (16
doublets, 24 CH), 126.5-134.5 (8 doublets, 8 Ci), 138.7 (dd,
C2, J PC ) 4.8, 1.6 Hz), 157.8 (d, C-OMe, J PC ) 9.7 Hz), 158.3
(d, C-OMe, J PC ) 10.6 Hz), 167.2 (dd, C1, J PC ) 128.0, 6.0
Hz) 168.2 (CdO).
P d I(C6F 5)(1a ) 3b. Reaction conditions as in 3a : THF, 60
°C, 96 h. Yield: 50 mg (51%) as orange brown crystals from
CH2Cl2 /Et2O/hexane. Mp: 260-265 °C (dec). Anal. Calcd
(found) for C44H32F5O2P2PdI (MW ) 983.0 g/mol): C, 53.76
(53.70); H, 3.28 (3.45). MS (FAB+, m/e): 855 [M - I]+, 815 [M
- C6F5]+, 688.1 [Pd(MeO-Biphep)]+. 31P NMR (121.5 MHz,
THF): δ, 20.9 (m (8 line multiplet)), 13.4 (m (ca. 15 lines)). 1H
NMR (300 MHz, CD2Cl2): δ, 3.39 (s, 3H, OCH3), 3.53 (s, 3H,
OCH3), 6.4-6.5 (m, 3H), 6.84 (m, 1H), 7.1-7.4 (m, 9H), 7.46
(m, 1H), 7.5-7.58 (m, 3H), 7.6-7.8 (m, 5H). 13C-19F HMQC:
δ, 122.1 (d, C1, J PC ) 118 Hz), 136.0/136.7 (C3/C5), 137.9 (C4),
145.0/145.7 (C2/C6). 13C{1H} NMR (100.6 MHz, CD2Cl2): δ,
3H), 6.39 (m, 1H), 6.52 (m, 1H), 6.7-7.8 (m, 33H). 13C{1H}
NMR (75.47 MHz, CD2Cl2): δ, 55.0 (2 OMe), 68.9 (d, b, J PC
)
26.8 Hz), 73.6 (b), 110.5 (CH ortho to OMe), 110.7 (CH ortho
to OMe), 122.0-135 (32 CH), 127-136 (10 Ci), 124.2 (b, CdC,
uncoord.), 143.5 (b, CdC uncoord.), 157.9 (d, C-OMe, J PC
)
7.9 Hz), 158.1 (d, C-OMe, J PC ) 7.6 Hz), 183.01 (b, CdO).
The structure of Pd(dba)(1b) was reported earlier. In contrast
to the observations made for Pd(dba)(1b), there appears to be
no restricted rotation around the P-C6H5 bonds of Pd(dba)-
1
(1a ), based on 31P,1H-correlation and H integration measure-
ments.
Two additional Pd(0) compexes were prepared, although not
discussed.
P d (cyclop en t -4-en e-1,3-d ion e)(1a ). Pd2(dba)3‚dba (57.5
mg, 0.05 mmol) and (S)-MeO-Biphep (58.3 mg, 0.1 mmol)
were dissolved in 2 mL of THF. To the orange-brown solution
formed was added 1.2 equiv of cyclopent-4-ene-1,3-dione (11.4
mg, 0.12 mmol). The color changed to yellow. After stirring
for 16 h the solution was filtered and taken to dryness in a
vacuum. The residue was washed with ether (7 × 1.0 mL).
The product can be recrystallized from CH2Cl2/Et2O. Yield: 78
mg (99%) as yellow microcrystals, mp 265 °C (dec). Anal. Calcd
(found) for C43H36O4P2Pd (MW ) 785.1 g/mol): C, 65.78 (65.78);
H, 4.62 (4.78). MS (FAB+, m/e): 785 [M + 1]+, 688 [Pd-
(MeOBiphep)]+. 31P{1H} NMR (121.5 MHz, CD2Cl2): δ, 28.4
(d, J ) 16.8 Hz), 26.2 (d, J ) 16.8 Hz).1H NMR (400.13 MHz,
CD2Cl2): δ, 2.33 (m, 1H), 2.80 (m, 1H), 3.44 (s, 3H), 3.47 (s,
3H), 4.36 (m, 1H), 4.80 (m, 1H), 6.28-6.36 (m, 2H), 6.51 (ddd,
1H, J ) 10.4, 7.9, 1.0 Hz), 6.59 (ddd, 1H, J ) 10.0, 7.9, 1.0
Hz), 6.83-7.83 (m, 22H). 13C{1H} NMR (100.62 MHz, CD2-
55.0 (OMe), 55.4 (OMe), 112.3 (d, J PC ) 2 Hz), 112.9 (d, J PC
)
2 Hz), 124.4 (dd, CH, J PC ) 11.0, 3.0 Hz), 125.3-137.8 (13
doublets, 19 CH), 126-134 (8 doublets, 8 Ci), 157.9 (d, C-OMe,
J PC ) 10 Hz), 158.3 (d, C-OMe, J PC ) 11 Hz). 19F NMR (282.4
MHz, CD2Cl2): δ, -113.5 (m, 1F), -115.4 (m, 1F), -163.1 (t,
1F, J ) 20), -164.2 (m, 1F), -165.2 (m, 1F). The complexity
arises from 2J (P,P) plus 19F spin-spin coupling.
P d Br (C6F 5)(1a ). Reaction conditions as in 3a : THF, 60 °C,
96 h. Yield: 48.8 mg (52%) as orange crystals from CH2Cl2
/Et2O/hexane. Mp; 275 °C (dec). Anal. Calcd (found) for
C
44H32F5O2P2PdBr (MW ) 936.0 g/mol): C, 56.46 (56.51); H,
3.44 (3.69). MS (FAB+, m/e): 855 [M - Br]+, 769.0 [M - C6F5]+,
688.1 [Pd(MeO-Biphep)]+. 31P NMR (121.5 MHz, CD2Cl2): δ,
27.45 (8 line multiplet, J PP ca. 29 Hz), 15.7 (ca. 15 line
multiplet, J PP ca. 29 Hz). 1H NMR (300 MHz, CD2Cl2): δ, 3.39
(s, 3H, OCH3), 3.53 (s, 3H, OCH3), 6.33-6.5 (m, 3H), 6.85 (td,
1H, J ) 8.1, 2.3 Hz), 7.09-7.34 (m, 9H), 7.41-7.55 (m, 4H),
7.62 (dd, 1H, J ) 11.5, 8.0 Hz), 7.65-7.74 (m, 2H), 7.76-7.86
(m, 2H). 13C-19F HMQC δ, 126.7 (d, C1, J PC ) 133 Hz), 135.9/
136.8 (C3/C5), 137.8 (C4), 145.2/146.0 (C2/C6). 13C{1H} NMR
(75.47 MHz, CD2Cl2): δ, 55.1 (OMe), 55.4 (OMe), 112.5 (d, J PC
) 2.6 Hz), 112.9 (d, J PC ) 2.6 Hz), 124.4 (dd, CH, J PC ) 10.6,
3.0 Hz), 125.1-137 (13 doublets, 19 CH), 126-134 (8 doublets,
8 Ci), 157.9 (d, C-OMe, J PC ) 10.4 Hz), 158.4 (d, C-OMe, J PC
) 11.3 Hz). 19F NMR (282.4 MHz, CD2Cl2): δ, -115.6 (m, 1F),
-116.5 (m, 1F), -163.1 (t, 1F, J ) 20), -164.0 (m, 1F), -165.83
(m, 1F). The complexity arises from 2J (P,P) plus 19F spin-
spin coupling.
Cl2): δ, 55.1 (OMe), 55.2 (OMe), 66.1 (CH2), 71.3 (dd, J PC
)
22.4, 2.7 Hz), 73.4 (dd, J PC ) 22.4, 2.3 Hz), 111.0-134.9 (18
doublets, 26 CH), 127-136 (8 doublets, Ci), 158.0 (d, C-OMe,
J PC ) 7.5 Hz), 158.1 (d, C-OMe, J PC ) 7.7 Hz), 200.8 (dd, Cd
O, J PC ) 4.3, 2.2 Hz), 201.9 (dd, CdO, J PC ) 5.0, 1.6 Hz).
P d (ben zoqu in on e)(1a ). Synthesis was performed as for
[Pd(cyclopente-4-ene-1,3-dione){(S)-MeO-Biphep}], but 2 equiv
of benzoquinone (21.6 mg, 0.2 mmol) was employed. Yield: 52
mg (65%) as red microcrystals, mp 210 °C (dec). Anal. Calcd
(found) for C44H36O4P2Pd (MW ) 797.1 g/mol): C, 66.3 (65.9);
H, 4.55 (5.09). MS (FAB+, m/e): 797 [M + 1]+, 688 [Pd(MeO-
Biphep)]+. 31P{1H} NMR (121.5 MHz, CD2Cl2): δ, 30.9. 1H
NMR (300.13 MHz, CD2Cl2): δ, 3.44 (s, 6H), 5.37 (m, 2H), 5.69
(m, 2H), 6.32 (m, b, 1H), 6.35 (m, b, 1H), 6.6 (m, 2H), 6.9 (m,
2H), 7.1-7.8 (m, 20H). 13C{1H} NMR (75.47 MHz, CD2Cl2):
δ, 55.1 (2 OMe), 104.21 (d, CH, J PC ) 3.5 Hz), 104.26 (d, CH,
J PC ) 3.5 Hz), 105.26 (d, CH, J PC ) 3.5 Hz), 105.31 (d, CH,
J PC ) 3.5 Hz), 111.3-135.2 (12 doublets, 3 broad signals, 26
P d Br (4-cya n op h en yl)(1a ). This was prepared as de-
scribed for 3a . Reaction conditions: THF, 40 °C, 14 h. Yield:
60 mg (69%) as yellow crystals from CH2Cl2/Et2O. Mp: 173
°C (dec). Anal. Calcd (found) for C45H36NO2P2PdBr (MW )
871.1 g/mol): C, 62.05 (61.78); H, 4.17 (4.35); N, 1.61 (1.62).
MS (FAB+, m/e) 790 [M - Br]+, 769.0 [M - C6H4CN]+, 688.1
[Pd(MeO-Biphep)]+. 31P NMR (121.5 MHz, THF): δ, 12.4 (d,
J ) 41.4 Hz), 26.9 (d, J ) 41.4 Hz). 1H NMR (400.13 MHz,
CD2Cl2): δ, 3.38 (s, 3H, OCH3), 3.49 (s, 3H, OCH3), 6.36-6.47
(m, 3H), 6.88 (td, 1H, J ) 8.2, 2.2 Hz), 6.96 (m, 2H, H3), 7.05-
7.37 (m, 12H), 7.43 (m, 1H), 7.47-7.52 (m, 3H), 7.57 (m, 2H,
H2), 7.64-7.72 (m, 2H), 7.74-7.85 (m, 4H). 13C{1H} NMR
(100.6 MHz, CD2Cl2): δ, 55.1 (OMe), 55.3 (OMe), 105.9 (d, C4,
J PC ) 1.6 Hz), 112.16 (d, J PC ) 2.5 Hz), 112.3 (d, J PC ) 1.6
Hz), 120.5 (d, CtN, J PC ) 0.7 Hz), 123.6-136.6 (16 doublets,
CH), 127.5-135.5 (8 doublets, Ci), 158.06 (d, C-OMe, J PC
)
5.2 Hz), 158.14 (d, C-OMe, J PC ) 5.2 Hz), 185.2 (d, CdO, J PC
) 3 Hz), 185.24 (d, CdO, J PC ) 3 Hz).
P d I(MeOOC-C6H4)(1a ), 3a . (S)-MeO-Biphep (58.3 mg,
0.1 mmol) and [PdI(TMEDA)(MeOOC-C6H4)] (48.5 mg, 0.1
mmol) were dissolved in 5 mL of THF and stirred at 40 °C for
14 h. The solution was filtered and taken to dryness. The
residue was washed with Et2O (5 × 2 mL) and the crude yellow
product recrystallyzed from CH2Cl2 and Et2O (1 mL CH2Cl2
condensed into the Schlenk tube and layered with Et2O). Over
a period of 24 h crystals were formed, which were washed with
Et2O and dried in a vacuum. Yield: 72.7 mg (76.4%) of yellow
crystals, mp 160 °C (dec). Anal. Calcd (found) for C46H39O4P2-
PdI (MW ) 951.1 g/mol) C, 58.09 (57.81); H, 4.13 (4.31). MS
(FAB+, m/e): 823.0 [Pd(C6H4COOMe)(MeO-Biphep)]+, 814.9
[PdI(MeO-Biphep)]+. 31P{1H} NMR (121.5 MHz, CD2Cl2): δ,
10.1 (J ) 42.7 Hz), 21.5 (J ) 42.7 Hz). 1H NMR (300 MHz,
CD2Cl2): δ, 3.34 (s, 3H, OCH3), 3.48 (s, 3H, OCH3), 3.79 (s,
3H, COOCH3), 6.36-6.41 (m, 2H), 6.44-6.51 (m, 1H), 6.8-
6.9 (m, 1H), 7.0-7.1 (m, 2H), 7.11-7.8 (m, 24H). 13C{1H} NMR
(100.6 MHz, CD2Cl2): δ, 51.7 (COOMe), 55.0 (OMe), 55.3
(OMe), 111.2 (d, J PC ) 1.6 Hz), 112.2 (d, J PC ) 1.6 Hz), 124.6
24 CH), 126.7-133.5 (8 doublets, 8 Ci), 129.2 (dd, C3, J PC
)
8.9, 1.8 Hz), 138.4 (dd, C2, J PC ) 5.0, 1.8 Hz), 157.8 (d, C-OMe,
J PC ) 10 Hz), 158.4 (d, C-OMe, J PC ) 11 Hz), 172.0 (dd, C1,
J PC ) 132.7, 4.1 Hz).
Bor oh ydr ide Rou te to P dBr (4-cyan oph en yl)(1a). NaBH4
and LiBHEt3 have been recently used to prepare zerovalent
complexes.47,48 NaBH4 (3.8 mg, 0.1 mmol) was added to a
(47) Wicht, D. K.; Zhuravel, M. A.; Gregush, R. V.; Glueck, D. S.;
Guzei, I. A.; Liable-Sands, L. M.; Rheingold, A. L. Organometallics
1998, 17, 1412-1419.